Skip to main content
LFWD
NASDAQ Industrial Applications And Services

Lifeward Q3 Revenue Falls 12% to $5.4M; Going-Concern Doubt Reaffirmed on $4.5M Cash

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$5.42
Mkt Cap
$16.237M
52W Low
$4.14
52W High
$9.61
52W Position info
31% above low
Off High info
44% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

LFWD sits 31% above its 52-week low of $4.14.

Summary

Lifeward posted Q3 revenue of $5.4 million, down 12%, and a $5.1 million net loss, while reaffirming that its $4.5 million of cash is not enough to fund the next twelve months. A Belgian regulator's demand to reclassify its Neo treadmills adds a new EU regulatory risk.


Key Events · Earnings and Guidance · LFWD

  • Q3 Revenue Falls 12%

    Revenue was $5.428 million versus $6.195 million a year earlier, as lower ReWalk sales in Europe and the U.S. — including the near-term effect of shifting to channel partners — offset an 18% increase in AlterG revenue to $3.6 million.

  • Cash Runway Under Twelve Months

    Cash and cash equivalents were $4.548 million at September 30, 2026, against $16.064 million of operating cash burn in the first nine months; management concluded substantial doubt exists about the ability to continue as a going concern for at least 12 months.

  • Loss Widened, Margin Compressed

    Q3 net loss was $5.052 million ($1.32 per share) versus $3.170 million a year earlier, and gross margin fell to 27.4% from 43.7% on tariffs, freight, foreign exchange and Oramed revenue-sharing expense. The quarter included a $1.347 million non-cash gain on warrant and derivative remeasurement.

  • EU Device Classification Challenge

    In November 2026 a Belgian authority told Lifeward its Neo and Neo+ Anti-Gravity Treadmills, marketed as Class I, should be at least Class IIa under Regulation (EU) 2017/745, requiring reclassification and a conformity assessment; continued EU marketing after the transition period depends on completing that process.


Analysis · LFWD · Industrial Applications And Services

Cash is the whole story here. Lifeward ended September with $4.5 million against $16.1 million of operating cash burn in the first nine months, and management states plainly that existing cash will not fund operations for the next twelve months. The going-concern warning is a reaffirmation rather than a new one, but the runway is now measured in months and the company says it must raise capital again. The quarter itself was weak: revenue fell 12% to $5.4 million as the ReWalk shift to channel partners cut near-term sales, and gross margin compressed to 27.4% from 43.7% on tariffs, freight and revenue-sharing costs. A $1.3 million non-cash gain on warrant and derivative remeasurement flatters the $5.1 million net loss, so the underlying operating loss of $6.0 million is the better read. Separately, a Belgian regulator has told the company its Neo and Neo+ treadmills should be Class IIa devices, which could interrupt EU sales of those products if reclassification is not completed in time.

How filings like this one have moved

In the 30 days to Nov 12, 2026, 47.3% of the 1873 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.17%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, LFWD was trading at $5.42 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $16.2M. The 52-week trading range was $4.14 to $9.61. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

LFWD - Latest Insights

LFWD
Nov 13, 2026, 9:17 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $5.72
Real-time Price: $5.42 info
Change: -$0.300 (-5%) info
Market Cap: $16.237M info
LFWD
Nov 05, 2026, 4:30 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $5.74
Real-time Price: $5.42 info
Change: -$0.320 (-6%) info
Market Cap: $16.237M info
LFWD
Oct 08, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $6.43
Real-time Price: $5.42 info
Change: -$1.01 (-16%) info
Market Cap: $16.237M info
LFWD
Sep 25, 2026, 4:45 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $6.99
Real-time Price: $5.42 info
Change: -$1.57 (-22%) info
Market Cap: $16.237M info
LFWD
Sep 15, 2026, 5:26 PM EDT
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $7.07
Real-time Price: $5.42 info
Change: -$1.65 (-23%) info
Market Cap: $16.237M info